Home» Circulars» Request For Data Submission: Rodtep Committee Fixing The Ceiling Rates For Pharma Industry Back
 
Request for Data Submission: RoDTEP Committee fixing the ceiling rates for Pharma Industry
 


PxlNwLtrHeaderLogo


PXL/HO/Cir-058/2020-21                                                                                       Date: 19.08.2020

Hyderabad

 

Dear Sir/Madam,

 

Subject: Request for Data Submission: RoDTEP Committee fixing the ceiling rates for Pharma Industry.

This is in continuation of our Circular dt: 12.August.2020 seeking inputs, we would like to bring to the kind notice of the member companies that Department of Revenue under the Chairmanship of Shri Gopal Pillai, Secretary (retd.) formed a Committee on RoDTEP for fixation of the ceiling rates under RoDTEP Scheme.

The Committee is interacting with all the Export promotion Councils for data submission by the member companies and RoDETP Committee in this context had a VC with Pharmexcil on 14.August, where in the undersigned had participated and requested to retain the same rates of MEIS.

The Committee has requested to shared data in the Formats R1, R2 and R3, which has been circulated to member companies on 13.August.2020 for submission of data within a stipulated time of ten days (by 22.August.2020), failing which the industry will not be having scope for recommending 3% or its equivalent.

Members are aware, MEIS is not a WTO Compliant Scheme and therefore RoDTEP is rolled out for incentivizing the industry in order to remain competitive and also to encourage exports. MEIS is going to be phased out by 31.Dec.2020 and RoDTEP comes into effect from Jan.2021, it is therefore vital for the industry to provide the data sought by the Committee with in the stipulated time.

In the absence of the timely inputs from the industry, the Committee might be taking a decision based on the data available with the Departments and fix the ceiling rates or possibly leave us behind for the next phase of discussions.

We therefore urge our member companies to take time and provide the data requested by the Department of Revenue in R1, R2 & R3 formats by/before 22.August to dgdesk@pharmexcil.com to enable Pharmexcil to consolidate the data and submit to the Committee within the timeline.

With regards,

 

Dr. Dinesh Dua

Chairman

 

Encl: Format